Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies-Reference-Cited by-同舟云学术

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies

Published:2012-12-20 Issue:12 Volume:7 Page:e52655
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dave Hema,Anver Miriam R.,Butcher Donna O.,Brown Patrick,Khan Javed,Wayne Alan S.,Baskar Sivasubramanian,Rader Christoph

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, et al.. (2003) Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program: 102–131.

2. Acute lymphoblastic leukemia;CH Pui;N Engl J Med,2004

3. The future role of monoclonal antibody therapy in childhood acute leukaemias;M Barth;Br J Haematol,2012

4. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children’s Oncology Group Pilot Study;EA Raetz;J Clin Oncol,2008

5. Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia;JF Dijoseph;Leukemia,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia;Hematological Oncology;2024-02-08

3. Anti-ROR1 CAR-T cells: Architecture and performance;Frontiers in Medicine;2023-02-17

4. Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1;Biomedicines;2022-10-13

5. ROR1-targeting switchable CAR-T cells for cancer therapy;Oncogene;2022-07-20